Stevens Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-5,387
| Closed | -$1M | – | 249 |
|
|
2025
Q2 | $1M | Buy |
+5,387
| New | +$1M | 0.27% | 69 |
|
|
2025
Q1 | – | Sell |
-5,654
| Closed | -$1M | – | 230 |
|
|
2024
Q4 | $1M | Buy |
+5,654
| New | +$1.04M | 0.4% | 60 |
|
|
2023
Q3 | – | Sell |
-5,955
| Closed | -$802K | – | 228 |
|
|
2023
Q2 | $802K | Buy |
+5,955
| New | +$873K | 0.16% | 123 |
|
|
2021
Q4 | – | Sell |
-2,435
| Closed | -$263K | – | 232 |
|
|
2021
Q3 | $263K | Buy |
+2,435
| New | +$278K | 0.11% | 145 |
|
|
2020
Q4 | – | Sell |
-20,944
| Closed | -$1.83M | – | 162 |
|
|
2020
Q3 | $1.83M | Sell |
20,944
-11,996
| -36% | -$1.13M | 0.68% | 41 |
|
|
2020
Q2 | $3.23M | Buy |
+32,940
| New | +$2.9M | 1.19% | 28 |
|
|
2020
Q1 | – | Sell |
-97,211
| Closed | -$8.61M | – | 3 |
|
|
2019
Q4 | $8.61M | Buy |
+97,211
| New | +$8.07M | 0.8% | 21 |
|
|
2019
Q3 | – | Sell |
-334,347
| Closed | -$24.3M | – | 537 |
|
|
2019
Q2 | $24.3M | Buy |
334,347
+12,289
| +4% | +$966K | 1.09% | 15 |
|
|
2019
Q1 | $26M | Buy |
+322,058
| New | +$26.3M | 1.11% | 7 |
|
|
2018
Q4 | – | Sell |
-370,702
| Closed | -$35.1M | – | 671 |
|
|
2018
Q3 | $35.1M | Buy |
370,702
+26,369
| +8% | +$2.5M | 1.28% | 5 |
|
|
2018
Q2 | $31.9M | Buy |
344,333
+193,863
| +129% | +$18.9M | 1.14% | 10 |
|
|
2018
Q1 | $14.2M | Buy |
+150,470
| New | +$16.5M | 0.54% | 40 |
|
|
2017
Q3 | – | Sell |
-330,831
| Closed | -$24M | – | 818 |
|
|
2017
Q2 | $24M | Buy |
330,831
+262,243
| +382% | +$17.6M | 0.9% | 11 |
|
|
2017
Q1 | $4.47M | Buy |
+68,588
| New | +$4.31M | 0.17% | 177 |
|
|
2016
Q4 | – | Sell |
-199,371
| Closed | -$12.6M | – | 839 |
|
|
2016
Q3 | $12.6M | Buy |
+199,371
| New | +$12.9M | 0.52% | 40 |
|
|
2016
Q2 | – | Sell |
-79,502
| Closed | -$4.54M | – | 873 |
|
|
2016
Q1 | $4.54M | Sell |
79,502
-2,878
| -3% | -$160K | 0.18% | 171 |
|
|
2015
Q4 | $4.88M | Sell |
82,380
-382,075
| -82% | -$22M | 0.19% | 155 |
|
|
2015
Q3 | $25.3M | Buy |
+464,455
| New | +$30.2M | 1.16% | 10 |
|
|
2015
Q1 | – | Sell |
-212,120
| Closed | -$13.9M | – | 959 |
|
|
2014
Q4 | $13.9M | Buy |
+212,120
| New | +$13.4M | 0.47% | 52 |
|
|
2014
Q2 | – | Sell |
-105,682
| Closed | -$5.43M | – | 1027 |
|
|
2014
Q1 | $5.43M | Buy |
105,682
+25,881
| +32% | +$1.31M | 0.15% | 172 |
|
|
2013
Q4 | $4.21M | Buy |
+79,801
| New | +$3.92M | 0.12% | 190 |
|
|
2013
Q3 | – | Sell |
-40,393
| Closed | -$1.67M | – | 994 |
|
|
2013
Q2 | $1.67M | Buy |
+40,393
| New | +$1.77M | 0.06% | 349 |
|
Other funds holding ABBV
Stevens Capital Management's ABBV Position: Q3 2025 in Review
Stevens Capital Management sold out of AbbVie (ABBV) in Q3 2025, closing a stake of 5,387 shares — an estimated $1M sold.
Stevens Capital Management first reported a position in ABBV in Q2 2013 and held it in 22 quarters. The position peaked at $35.1M in Q3 2018. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.
- Stevens Capital Management reported no remaining AbbVie position as of Q3 2025 after selling out during the quarter.
- Stevens Capital Management sold 5,387 AbbVie shares in Q3 2025, an estimated $1M.
- Stevens Capital Management first reported a position in AbbVie in Q2 2013 and held it in 22 quarters.
- Stevens Capital Management's AbbVie position peaked at $35.1M in Q3 2018.
- 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.
Based on Stevens Capital Management's 13F filing for Q3 2025, filed 10 Nov 2025.